A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT05400369 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD Exacerbation Acute

Interventions

DRUG: Sitafloxacin
DRUG: Moxifloxacin Hydrochloride

Sponsor

Daiichi Sankyo